Investing in tomorrow's medicine

 

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.

News

CEVA COMPLETES ACQUISITION OF IDT VETERINARY BUSINESS ASSETS, MOVING CLOSER TO ITS 2020 OBJECTIVE OF 50:50 BIO-PHARMA SPLIT

03/07/2019

Ceva and IDT have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.

SuperSonic Imagine announces that it has received a binding offer from the Hologic group to acquire 100% of the Company’s capital for a price of €1.50 per share

21/06/2019

Hologic is planning to acquire a controlling stake of approximately 46% of the Company’s capital.

Xeris Pharmaceuticals Announces Additional Positive Outcomes from a Global Phase 3 Clinical Trial of Its Investigational Ready-to-Use Glucagon

17/06/2019

Findings will support application for European marketing authorization and augment body of data supporting efficacy and utility of its stable liquid glucagon.

Key figures

25
Supported Companies
20
Team
525
Assets Under Management
(€ million)
3
Offices